Table 1.
Baseline Characteristics | Total | PUD Recurrence (+) | PUD Recurrence (−) | P-value |
---|---|---|---|---|
Number | 1,420 | 118 | 1,302 | |
Sociodemographic factors | ||||
Age | 68.70 ± 8.66 | 71.62 ± 9.86 | 68.71 ± 8.50 | 0.062 |
Female gender | 687 (48.4%) | 57 (48.3%) | 630 (48.4%) | 0.078 |
Body mass index (BMI) | 23.6 ± 3.2 | 23.7 ± 3.3 | 23.6 ± 3.2 | 0.727 |
Living under local poverty line | 213 (15.0%) | 23 (19.5%) | 190 (14.6%) | 0.042 |
Pre-existing peptic ulcer locations | 0.568 | |||
Gastric | 550 (38.7%) | 45 (38.1%) | 505 (38.8%) | |
Duodenal | 834 (58.7%) | 69 (58.5%) | 765 (58.8%) | |
Gastric-duodenal | 36 (2.5%) | 4 (3.4%) | 32 (2.5%) | |
Medical conditions | ||||
Cardiovascular disease | 393 (27.7%) | 43 (36.4%) | 350 (26.9%) | 0.009 |
Cerebrovascular disease | 341 (24.0%) | 32 (27.1%) | 309 (23.7%) | 0.058 |
Diabetes mellitus | 426 (30.0%) | 39 (33.1%) | 387 (29.7%) | 0.055 |
Renal disease | 111 (7.8%) | 10 (8.5%) | 101 (7.8%) | 0.091 |
Liver disease | 253 (17.8%) | 20 (16.9%) | 233 (17.9%) | 0.098 |
Cognitive status (C-MMSE) | 21.85 ± 4.76 | 21.07 ± 5.18 | 22.09 ± 4.08 | 0.627 |
Cigarette smoking | 398 (28.0%) | 33 (28.0%) | 365 (28.0%) | 0.259 |
Excessive alcohol consumption | 94 (6.6%) | 22 (18.6%) | 72 (5.5%) | <0.001 |
Psychological factors | ||||
Depressive symptoms | 326 (23.0%) | 47 (39.8%) | 279 (21.4%) | <0.001 |
Generalized Anxiety Disorders | 369 (26.0%) | 37 (31.4%) | 332 (25.5%) | 0.027 |
Sleep quality (0–21) | 7.03 ± 4.41 | 11.73 ± 4.43 | 6.58 ± 4.12 | <0.001 |
Good (0–4) | 852 (60.0%) | 56 (47.5%) | 796 (61.1%) | |
Poor (5–21) | 568 (40.0%) | 62 (52.5%) | 506 (38.9%) | |
Poor sleep quality + increased social engagement | 218 (15.4%) | 17 (14.4%) | 201 (15.4%) | |
Poor sleep quality + continued social engagement | 182 (12.8%) | 16 (13.6%) | 166 (12.7%) | |
Poor sleep quality + decreased social engagement | 108 (7.6%) | 18 (15.3%) | 90 (6.9%) | |
Poor sleep quality + no social engagement | 60 (4.2%) | 11 (9.3%) | 49 (3.8%) | |
Follow-up characteristics | ||||
H. pylori reinfection | 182 (12.8%) | 80 (67.8%) | 102 (7.8%) | <0.001 |
Duration of follow-up | 34.62 ± 3.17 | 33.88 ± 3.68 | 34.83 ± 3.01 | 0.126 |
†Data presented as number (%), mean (SD).